Our Mission
The ACC Nevada Chapter is dedicated to advancing the field of cardiovascular care through innovation, advocacy, and professional development, ensuring that Nevada’s clinicians are equipped to meet the evolving health challenges of our state.
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- ALLEPRE: Nurse-Coordinated Prevention Program May Reduce Long-Term CV RiskImplementing a nurse-coordinated prevention program (NCPP) significantly reduced long-term major adverse cardiovascular events (MACE) and improved body weight control, physical activity and pharmacotherapy adherence in post-hospitalization patients with acute coronary syndrome (ACS), according to results from the ALLEPRE trial published May 5 in EHJ.
- Rising HDP Rates in the US; BP Monitoring Across the LifespanThe rate of new-onset hypertensive disorders of pregnancy (HDP) in the U.S. increased significantly from 2016 to 2024 across all racial and ethnic groups, according to a brief JACC report – the importance of which is further echoed in a longer systematic review of blood pressure (BP) monitoring across a patient's lifespan published in JACC's […]
- Ivabradine vs. Propranolol For POTS; Testosterone Prescribing TrendsBoth ivabradine and propranolol reduced tachycardia and symptoms of postural orthostatic tachycardia syndrome (POTS), compared with placebo, based on findings from a randomized, double-blind crossover trial published in JACC and JACC: Advances.
-  Eagle’s Eye View: Can Rhythm Control Improve Tricuspid Regurgitation?In this week’s View, Dr. Eagle examines the role of rhythm control in improving moderate-to-severe and severe secondary tricuspid valve regurgitation.
- FASTR: Reprieve System Safely Accelerates Decongestion in Acute HFThe Reprieve System, a three-part approach to diuretic therapy, safely produced significantly faster decongestion in patients with acute heart failure (HF) compared with optimal diuretic therapy (ODT), according to results of the FASTR trial published May 4 in JACC: Heart Failure.